Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion

Anne von Mässenhausen; Nadia Zamora Gonzalez; Francesca Maremonti; Alexia Belavgeni; Wulf Tonnus; Claudia Meyer; Kristina Beer; Monica T. Hannani; Arthur Lau; Mirko Peitzsch; Paul Hoppenz; Sophie Locke; Triantafyllos Chavakis; Rafael Kramann; Daniel A. Muruve; Christian Hugo; Stefan R. Bornstein; Andreas Linkermann

doi:10.1126/sciadv.abl8920

Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion

Anne von Mässenhausen, Nadia Zamora Gonzalez, Francesca Maremonti, Alexia Belavgeni, Wulf Tonnus, Claudia Meyer, Kristina Beer, Monica T. Hannani, Arthur Lau, Mirko Peitzsch, Paul Hoppenz, Sophie Locke, Triantafyllos Chavakis, Rafael Kramann, Daniel A. Muruve, Christian Hugo, Stefan R. Bornstein, Andreas Linkermann^*

^*Corresponding author for this work

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

39 Downloads (Pure)

Abstract

Dexamethasone is widely used as an immunosuppressive therapy and recently as COVID-19 treatment. Here, we demonstrate that dexamethasone sensitizes to ferroptosis, a form of iron-catalyzed necrosis, previously suggested to contribute to diseases such as acute kidney injury, myocardial infarction, and stroke, all of which are triggered by glutathione (GSH) depletion. GSH levels were significantly decreased by dexamethasone. Mechanistically, we identified that dexamethasone up-regulated the GSH metabolism regulating protein dipeptidase-1 (DPEP1) in a glucocorticoid receptor (GR)-dependent manner. DPEP1 knockdown reversed the phenotype of dexamethasone-induced ferroptosis sensitization. Ferroptosis inhibitors, the DPEP1 inhibitor cilastatin, or genetic DPEP1 inactivation reversed the dexamethasone-induced increase in tubular necrosis in freshly isolated renal tubules. Our data indicate that dexamethasone sensitizes to ferroptosis by a GR-mediated increase in DPEP1 expression and GSH depletion. Together, we identified a previously unknown mechanism of glucocorticoid-mediated sensitization to ferroptosis bearing clinical and therapeutic implications.

Original language	English
Article number	eabl8920
Journal	Science advances
Volume	8
Issue number	5
DOIs	https://doi.org/10.1126/sciadv.abl8920
Publication status	Published - 2 Feb 2022

Bibliographical note

Funding Information:
We would like to thank R. Opitz, C. Laqua, and A. Pioch for expert technical assistance, M. Langner for expert help with mass spectrometry, and the Light Microscopy Facility at Dresden BIOTEC, in particular H. Hartmann and E. Geibelt, for the expert help. We thank the Microstructure Facility of the BIOTEC at Technische Universitat Dresden [partly funded by the State of Saxony and the European Fund for Regional Development-EFRE (100344812)]. Work in the Linkermann laboratory is funded by the SFB-TRR 205, SFB-TRR 127, and the international research training group (IRTG) 2251. This work was additionally supported by the German Research Foundation (DFG), priority program on ferroptosis (SPP2306) to A.v.M. and A.L., the Heisenberg-Professorship to A.L. (project number 324141047), and an instrument grant support to M.P. (INST 515/28-1 FUGG). We further thank the Else Kr?ner-Fresenius Stiftung and the Sander-Stiftung for supporting our laboratory.

Publisher Copyright:
© 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Access to Document

10.1126/sciadv.abl8920Licence: CC BY

Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor–induced dipeptidase-1 expression and glutathione depletionFinal published version, 2.23 MBLicence: CC BY

Cite this

von Mässenhausen, A., Gonzalez, N. Z., Maremonti, F., Belavgeni, A., Tonnus, W., Meyer, C., Beer, K., Hannani, M. T., Lau, A., Peitzsch, M., Hoppenz, P., Locke, S., Chavakis, T., Kramann, R., Muruve, D. A., Hugo, C., Bornstein, S. R., & Linkermann, A. (2022). Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Science advances, 8(5), [eabl8920]. https://doi.org/10.1126/sciadv.abl8920

@article{ae3ac27be7754d11b7b9fa7e235ae611,

title = "Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion",

abstract = "Dexamethasone is widely used as an immunosuppressive therapy and recently as COVID-19 treatment. Here, we demonstrate that dexamethasone sensitizes to ferroptosis, a form of iron-catalyzed necrosis, previously suggested to contribute to diseases such as acute kidney injury, myocardial infarction, and stroke, all of which are triggered by glutathione (GSH) depletion. GSH levels were significantly decreased by dexamethasone. Mechanistically, we identified that dexamethasone up-regulated the GSH metabolism regulating protein dipeptidase-1 (DPEP1) in a glucocorticoid receptor (GR)-dependent manner. DPEP1 knockdown reversed the phenotype of dexamethasone-induced ferroptosis sensitization. Ferroptosis inhibitors, the DPEP1 inhibitor cilastatin, or genetic DPEP1 inactivation reversed the dexamethasone-induced increase in tubular necrosis in freshly isolated renal tubules. Our data indicate that dexamethasone sensitizes to ferroptosis by a GR-mediated increase in DPEP1 expression and GSH depletion. Together, we identified a previously unknown mechanism of glucocorticoid-mediated sensitization to ferroptosis bearing clinical and therapeutic implications.",

author = "{von M{\"a}ssenhausen}, Anne and Gonzalez, {Nadia Zamora} and Francesca Maremonti and Alexia Belavgeni and Wulf Tonnus and Claudia Meyer and Kristina Beer and Hannani, {Monica T.} and Arthur Lau and Mirko Peitzsch and Paul Hoppenz and Sophie Locke and Triantafyllos Chavakis and Rafael Kramann and Muruve, {Daniel A.} and Christian Hugo and Bornstein, {Stefan R.} and Andreas Linkermann",

note = "Funding Information: We would like to thank R. Opitz, C. Laqua, and A. Pioch for expert technical assistance, M. Langner for expert help with mass spectrometry, and the Light Microscopy Facility at Dresden BIOTEC, in particular H. Hartmann and E. Geibelt, for the expert help. We thank the Microstructure Facility of the BIOTEC at Technische Universitat Dresden [partly funded by the State of Saxony and the European Fund for Regional Development-EFRE (100344812)]. Work in the Linkermann laboratory is funded by the SFB-TRR 205, SFB-TRR 127, and the international research training group (IRTG) 2251. This work was additionally supported by the German Research Foundation (DFG), priority program on ferroptosis (SPP2306) to A.v.M. and A.L., the Heisenberg-Professorship to A.L. (project number 324141047), and an instrument grant support to M.P. (INST 515/28-1 FUGG). We further thank the Else Kr?ner-Fresenius Stiftung and the Sander-Stiftung for supporting our laboratory. Publisher Copyright: {\textcopyright} 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).",

year = "2022",

month = feb,

day = "2",

doi = "10.1126/sciadv.abl8920",

language = "English",

volume = "8",

journal = "Science advances",

issn = "2375-2548",

publisher = "American Association for the Advancement of Science",

number = "5",

}

von Mässenhausen, A, Gonzalez, NZ, Maremonti, F, Belavgeni, A, Tonnus, W, Meyer, C, Beer, K, Hannani, MT, Lau, A, Peitzsch, M, Hoppenz, P, Locke, S, Chavakis, T, Kramann, R, Muruve, DA, Hugo, C, Bornstein, SR & Linkermann, A 2022, 'Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion', Science advances, vol. 8, no. 5, eabl8920. https://doi.org/10.1126/sciadv.abl8920

TY - JOUR

T1 - Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion

AU - von Mässenhausen, Anne

AU - Gonzalez, Nadia Zamora

AU - Maremonti, Francesca

AU - Belavgeni, Alexia

AU - Tonnus, Wulf

AU - Meyer, Claudia

AU - Beer, Kristina

AU - Hannani, Monica T.

AU - Lau, Arthur

AU - Peitzsch, Mirko

AU - Hoppenz, Paul

AU - Locke, Sophie

AU - Chavakis, Triantafyllos

AU - Kramann, Rafael

AU - Muruve, Daniel A.

AU - Hugo, Christian

AU - Bornstein, Stefan R.

AU - Linkermann, Andreas

N1 - Funding Information: We would like to thank R. Opitz, C. Laqua, and A. Pioch for expert technical assistance, M. Langner for expert help with mass spectrometry, and the Light Microscopy Facility at Dresden BIOTEC, in particular H. Hartmann and E. Geibelt, for the expert help. We thank the Microstructure Facility of the BIOTEC at Technische Universitat Dresden [partly funded by the State of Saxony and the European Fund for Regional Development-EFRE (100344812)]. Work in the Linkermann laboratory is funded by the SFB-TRR 205, SFB-TRR 127, and the international research training group (IRTG) 2251. This work was additionally supported by the German Research Foundation (DFG), priority program on ferroptosis (SPP2306) to A.v.M. and A.L., the Heisenberg-Professorship to A.L. (project number 324141047), and an instrument grant support to M.P. (INST 515/28-1 FUGG). We further thank the Else Kr?ner-Fresenius Stiftung and the Sander-Stiftung for supporting our laboratory. Publisher Copyright: © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

PY - 2022/2/2

Y1 - 2022/2/2

N2 - Dexamethasone is widely used as an immunosuppressive therapy and recently as COVID-19 treatment. Here, we demonstrate that dexamethasone sensitizes to ferroptosis, a form of iron-catalyzed necrosis, previously suggested to contribute to diseases such as acute kidney injury, myocardial infarction, and stroke, all of which are triggered by glutathione (GSH) depletion. GSH levels were significantly decreased by dexamethasone. Mechanistically, we identified that dexamethasone up-regulated the GSH metabolism regulating protein dipeptidase-1 (DPEP1) in a glucocorticoid receptor (GR)-dependent manner. DPEP1 knockdown reversed the phenotype of dexamethasone-induced ferroptosis sensitization. Ferroptosis inhibitors, the DPEP1 inhibitor cilastatin, or genetic DPEP1 inactivation reversed the dexamethasone-induced increase in tubular necrosis in freshly isolated renal tubules. Our data indicate that dexamethasone sensitizes to ferroptosis by a GR-mediated increase in DPEP1 expression and GSH depletion. Together, we identified a previously unknown mechanism of glucocorticoid-mediated sensitization to ferroptosis bearing clinical and therapeutic implications.

AB - Dexamethasone is widely used as an immunosuppressive therapy and recently as COVID-19 treatment. Here, we demonstrate that dexamethasone sensitizes to ferroptosis, a form of iron-catalyzed necrosis, previously suggested to contribute to diseases such as acute kidney injury, myocardial infarction, and stroke, all of which are triggered by glutathione (GSH) depletion. GSH levels were significantly decreased by dexamethasone. Mechanistically, we identified that dexamethasone up-regulated the GSH metabolism regulating protein dipeptidase-1 (DPEP1) in a glucocorticoid receptor (GR)-dependent manner. DPEP1 knockdown reversed the phenotype of dexamethasone-induced ferroptosis sensitization. Ferroptosis inhibitors, the DPEP1 inhibitor cilastatin, or genetic DPEP1 inactivation reversed the dexamethasone-induced increase in tubular necrosis in freshly isolated renal tubules. Our data indicate that dexamethasone sensitizes to ferroptosis by a GR-mediated increase in DPEP1 expression and GSH depletion. Together, we identified a previously unknown mechanism of glucocorticoid-mediated sensitization to ferroptosis bearing clinical and therapeutic implications.

UR - http://www.scopus.com/inward/record.url?scp=85123974058&partnerID=8YFLogxK

U2 - 10.1126/sciadv.abl8920

DO - 10.1126/sciadv.abl8920

M3 - Article

C2 - 35108055

AN - SCOPUS:85123974058

VL - 8

JO - Science advances

JF - Science advances

SN - 2375-2548

IS - 5

M1 - eabl8920

ER -

Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this